Patients, advocates, and experts fear the difficulty in documenting a frailty exemption to Medicaid work requirements will ...
Ten years ago, the World Health Organization added mycetoma to its official list of neglected tropical diseases. Caused by ...
A group of outside experts convened by the Food and Drug Administration on Thursday voted in favor of Replimune’s experimental treatment for advanced melanoma. In a 10-3 vote, t ...
Is the FDA taking inconsistent approaches to Duchenne drugs? And how will a new batch of drug executives shake up their ...
In win for RFK Jr., Senate committee sends nominations of Erica Schwartz for CDC director and Sean Kaufman for ASPR to full ...
An FDA advisory panel concluded clinical data for a Capricor treatment for Duchenne muscular dystrophy did not provide ...
Students working in fields eligible for NSF funding will be able to participate, including chemistry, engineering, and basic ...
Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. BOSTON — In an order issued Thursday, a federal judge denied 26 ...
Latigo Biotherapeutics published positive data for an acute-pain drug meant to rival a Vertex medicine already on the market ...
The discovery that a fugitive had been working under an alias in the biotech industry prompted a question: How did he evade ...
The U.S. Federal Trade Commission sued telehealth company Hims & Hers alleging business practices that agency says misled ...
Here are some things STAT will be watching for during Wednesday’s hearing: Health secretary Robert F. Kennedy Jr. and Paul ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results